tiprankstipranks
Voyager Therapeutics (VYGR)
NASDAQ:VYGR
US Market

Voyager Therapeutics (VYGR) Income Statement

Compare
690 Followers

Voyager Therapeutics Income Statement

Last quarter (Q4 2024), Voyager Therapeutics's total revenue was $6.28M, a decrease of -93.03% from the same quarter last year. In Q4, Voyager Therapeutics's net income was $-34.49M. See Voyager Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 80.00M$ 250.01M$ 40.91M$ 37.41M$ 171.13M
Gross Profit
$ 80.00M$ 245.57M$ 34.72M$ -36.37M$ 62.38M
Operating Expenses
$ 163.29M$ 127.99M$ 91.74M$ 111.03M$ 143.74M
Depreciation and Amortization
$ 0.00$ 4.44M$ 6.19M$ 5.17M$ 3.82M
EBITDA
$ -83.29M$ 126.45M$ -44.65M$ -68.45M$ 31.20M
Operating Income
$ -83.29M$ 122.01M$ -50.84M$ -73.62M$ 27.38M
Other Income/Expenses
$ 18.95M$ 11.72M$ 4.45M$ 2.42M$ 9.36M
Pretax Income
$ -64.34M$ 133.74M$ -46.39M$ -71.20M$ 36.74M
Net Income
$ -65.00M$ 132.33M$ -46.41M$ -66.03M$ 36.74M
Per Share Metrics
Basic EPS
$ -1.13$ 3.08$ -1.21$ -1.75$ 0.99
Diluted EPS
$ -1.13$ 2.97$ -1.21$ -1.75$ 0.98
Weighted Average Shares Outstanding
57.67M 43.02M 38.36M 37.67M 37.13M
Weighted Average Shares Outstanding (Diluted)
57.67M 44.57M 38.36M 37.67M 37.35M
Currency in USD

Voyager Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis